A Study of Famitinib in Patients With Gastrointestinal Stromal Tumor

NCT02336724 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

88

Enrollment

INDUSTRY

Sponsor class

Conditions

Gastrointestinal Stromal Tumor

Interventions

DRUG: Famitinib

Sponsor

Jiangsu HengRui Medicine Co., Ltd.